Top compounds associated with response to CLDN11


Feature Type Standardized
Nominal ANOVA
mRNA CIL41 CTRPv2 pan-cancer AAC -0.017 0.7
mRNA Fumonisin B1 CTRPv2 pan-cancer AAC -0.013 0.7
mRNA ABT-888 CTRPv2 pan-cancer AAC -0.012 0.7
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.01 0.7
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.012 0.7
mRNA myricetin CTRPv2 pan-cancer AAC 0.013 0.7
mRNA piperlongumine GDSC1000 pan-cancer AAC -0.011 0.7
mRNA RDEA119 GDSC1000 pan-cancer AAC -0.01 0.7
mRNA AZ-3146 CTRPv2 pan-cancer AAC -0.012 0.7
mRNA simvastatin CTRPv2 pan-cancer AAC 0.013 0.7
Download CSV